Inside information - progress of the potential capital increase of CNGT through public tender
Filed with HKEX · Stock code 1763 · · 5 pages · English
Summary by 6ix AI
This filing is an inside information announcement regarding the progress of a potential capital increase for Chengdu Gaotong Isotope Co., Ltd. through a public tender process. The announcement outlines the qualifications for prospective investors, the procedures for the public tender, and the intended use of proceeds from the capital increase. It also discusses the expected effects of the capital increase on the company's shareholding structure and its financial implications under listing rules. The company emphasizes that the potential capital increase has not yet materialized and that there is no assurance it will proceed.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
China Isotope & Radiation Corp. on 6ix
Earlier from China Isotope & Radiation
- (UPDATED) Interim Dividend for the Six Months Ended 30 June 2026
- List of directors and their role and function
- Poll results of extraordinary general meeting
- An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
- Voluntary announcement - zhonghe headway's 50mg Urea 13C breath test kit has obtained the drug registration certificate
Later from China Isotope & Radiation
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2026
- Change of company secretary, authorised representative and process agent waiver from strict compliance with rules 3.28 and 8.17 of the listing rules and change of investor relations contact details
Follow China Isotope & Radiation into a list and get an email when it puts out news.
Follow China Isotope & Radiation